JOHNSON & JOHNSON (JNJ) Insider Trading

Healthcare · Pharmaceutical Preparations

Open-market and disclosed Form 4 insider trading for JOHNSON & JOHNSON (JNJ) on InvestAtlant.

Recent insider transactions

DateInsiderTitleTypeValue
2026-09-02 Schmid Timothy EVP, WW Chair, MedTech Sale $3.04M
2026-09-02 Schmid Timothy EVP, WW Chair, MedTech Sale $6.19M
2026-08-17 Taubert Jennifer L EVP, WWC. Innovative Medicine Sale $3.95M
2026-08-13 Duato Joaquin CEO and Chairman of the Board, Director Sale $26.70M
2026-08-13 Duato Joaquin CEO and Chairman of the Board, Director Sale $5.50M
2026-08-06 Forminard Elizabeth EVP, Chief Legal Officer Sale .68M
2026-08-06 Forminard Elizabeth EVP, Chief Legal Officer Sale $2.41M
2026-08-05 Duato Joaquin CEO and Chairman of the Board, Director Sale 0.83M

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.